Amicus Therapeutics – Corporate Giving / Charitable Contributions Program

Charitable Contributions Supporting Rare Disease Education, Advocacy, Access, and Patient Community Initiatives

Amicus Therapeutics provides charitable contributions to nonprofit healthcare-related organizations working to enhance the lives of rare disease communities. Through its corporate giving program, Amicus supports patient and professional organizations delivering programs, services, and activities focused on public health, patient experiences, disease awareness, education, advocacy, access, and improved outcomes in disease areas related to the company’s therapeutic focus.

Organization: Amicus Therapeutics
Support Type: Charitable contributions
Geographic Focus: United States and international, for eligible nonprofit organizations
Deadline: Rolling; requests should be submitted at least 90 days before the proposed program, event, or activity

New to corporate grant fundraising?
Read our Corporate Grants for Nonprofits: Ultimate Guide to learn how corporate funding works.

About the Funder

Amicus Therapeutics is a biotechnology company focused on developing therapies for people living with rare diseases. Through its charitable giving program, Amicus supports nonprofit organizations that serve rare disease communities and help improve education, advocacy, access, awareness, patient experiences, and health outcomes.

What This Program Supports

Amicus considers charitable contribution requests that support healthcare-related nonprofit programs, services, and activities designed to benefit rare disease communities.

Eligible charitable activities may include:

Patient Community Education
Programs that provide disease education, resources, and information to patients, families, caregivers, and rare disease communities.

Advocacy Initiatives
Efforts that strengthen patient advocacy, elevate patient voices, and support community engagement around rare disease needs.

Disease Awareness
Programs designed to increase awareness and understanding of rare diseases and related patient experiences.

Access Initiatives
Activities that help address barriers to information, resources, care, or support for rare disease communities.

Improvement in Patient Disease Outcomes
Programs that seek to improve patient experiences, support better outcomes, or respond to unmet needs within rare disease communities.

Eligible Organizations

Amicus Therapeutics will review charitable requests from nonprofit organizations described in Sections 501(c)(3) and 509(a)(1), 509(a)(2), or 509(a)(3) of the U.S. Internal Revenue Code, as well as similarly designated nonprofit organizations based outside the United States.

Eligible organization types may include:

Patient advocacy organizations
Healthcare-related humanitarian organizations
Healthcare industry associations
Academic centers engaged in disease and patient education
Patient, professional, medical, and scientific associations
Community service organizations

Eligible Support Types

Charitable contributions
Support for patient education programs
Support for advocacy initiatives
Support for disease awareness efforts
Support for access-related initiatives
Support for programs intended to improve patient disease outcomes

Eligibility & Preferences

Requests should be submitted by eligible nonprofit healthcare-related organizations and should support charitable activities that benefit rare disease communities.

Applicants should be able to demonstrate:

Clear nonprofit or charitable status
A healthcare, patient, professional, scientific, academic, advocacy, or community-service purpose
Alignment with Amicus’ rare disease focus and charitable giving priorities
A clear description of the proposed program, event, or activity
A defined budget and requested funding amount
How the activity will benefit patients, families, caregivers, professionals, or rare disease communities

Amicus does not receive significant value in goods or services in return for its charitable support.

Required Documents

Applications will only be considered for review once all required documentation has been submitted.

Required materials include:

Letter of Request on the nonprofit organization’s letterhead, submitted as a PDF
Program or project title
Program, event, or activity date(s)
Location(s)
Description of the proposed activity
Estimated budget
Amount of funding requested from Amicus
Statement indicating whether co-funding is being sought from other companies or entities
Agenda, if the request is for an event or program
Copy of tax-exempt charitable status documentation, such as a current 990 form dated within the last two years, 501(c)(3) letter, excerpt from register, or equivalent documentation
Current IRS W-9 form for U.S. nonprofits, signed and dated within the last 12 months
Equivalent foreign documentation for non-U.S. organizations
Amicus Payment Info Form

Ineligible Requests

Amicus does not publish a detailed list of ineligible charitable contribution requests on the program page. However, requests must comply with applicable federal, state, local, country, industry, and academic rules and guidelines governing charitable contribution activities.

Requests that are incomplete, submitted without required documentation, or not aligned with Amicus’ charitable contribution guidelines may not be considered.

Funding Amounts

Amicus Therapeutics does not publish standard charitable contribution amounts. Applicants must include an estimated budget and the amount requested from Amicus as part of the Letter of Request.

Timeline & Review

📅 Application Deadline: Rolling
📅 Minimum Lead Time: Submit at least 90 days before the proposed program, event, or activity
📅 Best Time to Submit Annual Requests: Early in the third quarter for support needed during the following calendar year
📅 Review Requirement: Applications are considered only after all required documentation is submitted

Because Amicus begins annual budget preparations early in the third quarter, organizations seeking support for the following calendar year are encouraged to submit requests during that period.

Application / Request Process

Applicants should submit charitable contribution requests through the Amicus online system.

First-time applicants must first confirm eligibility, register, and submit a request through the online portal. Returning applicants may log in with their existing email address and password.

Applicants should ensure cookies and JavaScript are enabled in their browser in order to access the system successfully.

For questions, applicants may contact Amicus at Grants@amicusrx.com, call toll-free in the United States at 1-866-9AMICUS / 1-866-926-4287, or call +44-1753-888-567 for international inquiries.

Apply / Learn More:
➡️ Amicus Therapeutics Corporate Giving

Why This Opportunity Is a Good Fit

This opportunity is a strong fit for organizations that:

Serve rare disease communities
Provide patient education, disease awareness, advocacy, or access programs
Are nonprofit healthcare-related organizations, patient advocacy organizations, academic centers, professional associations, or community service organizations
Can document charitable status and provide required financial and tax documentation
Have a clear program budget and defined funding request
Can submit a complete request at least 90 days before the proposed activity
Are planning ahead for the next calendar year and can submit during the early third quarter budget planning period

Amicus Therapeutics’ Corporate Giving program is best suited for healthcare-related nonprofits and patient organizations working to improve rare disease education, advocacy, access, patient experiences, and outcomes.

Corporate Grants Guide Notes

Review Type: Rolling review
Deadline: Rolling; submit at least 90 days before the proposed program, event, or activity
Best Annual Planning Window: Early third quarter for following-year requests
Support Type: Charitable contributions
Funding Amount: Not published
Best Suited For: Rare disease patient advocacy organizations, healthcare-related nonprofits, academic centers, medical and scientific associations, and community organizations supporting rare disease education, awareness, advocacy, access, and patient outcomes